Pharvaris NV (PHVS)
38.17
+0.43
(+1.14%)
USD |
NASDAQ |
Sep 10, 12:50
Pharvaris Total Assets (Quarterly) : 375.77M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 375.77M |
| March 31, 2026 | 299.33M |
| December 31, 2025 | 354.04M |
| September 30, 2025 | 398.20M |
| June 30, 2025 | 246.29M |
| March 31, 2025 | 267.96M |
| December 31, 2024 | 301.72M |
| September 30, 2024 | 349.52M |
| June 30, 2024 | 377.09M |
| March 31, 2024 | 407.80M |
| December 31, 2023 | 440.42M |
| September 30, 2023 | 179.29M |
| June 30, 2023 | 207.01M |
| March 31, 2023 | 160.58M |
| Date | Value |
|---|---|
| December 31, 2022 | 179.01M |
| September 30, 2022 | 198.85M |
| June 30, 2022 | 216.14M |
| March 31, 2022 | 223.79M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 123.70M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 23.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 122.03B |
| BioAge Labs, Inc. | 396.93M |
| AstraZeneca PLC | 114.02B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.85M |
| Shareholders Equity (Quarterly) | 343.92M |
| Debt to Equity Ratio | 0.0022 |
| Current Ratio | 11.94 |
| Net Debt Paydown Yield | 0.00% |